Literature DB >> 1349600

Measurement of cell proliferation in gastric carcinoma: comparative analysis of Ki-67 and proliferative cell nuclear antigen (PCNA).

J C Rosa1, R Mendes, M I Filipe, R W Morris.   

Abstract

Immunostaining to identify nuclear antigens expressed throughout the cell cycle provides a convenient way of assessing proliferating kinetics in tumours. We studied proliferation activity of gastric carcinomas by Ki-67 and PCNA immunostaining and the two methods were compared. The mode of tissue preparation differed, fresh frozen for Ki-67 and formalin-fixed paraffin-embedded for PCNA. Immunostaining with avidin-biotin was used in both. The labelling index (LI) and a semi-quantitative grading of cell proliferation were assessed in both markers. Significant correlation was shown between LI and grading with either Ki-67 and PCNA. However, no correlation was found between PCNA and Ki-67. This lack of relationship between the two markers may be attributed to a number of factors. 1. The most likely is the marked inter- and intra-tumour heterogeneity of gastric carcinomas reflected in high standard deviation values. 2. Preparation of tissue and small size sampling with Ki-67. 3. Long life of PCNA leading to detection of cells that have recently left the cell cycle. 4. One may be observing deregulated expression of DNA as seen in certain tumours. PCNA offers the advantage of being applicable to archival material.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1349600     DOI: 10.1007/bf01082445

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  19 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

Review 2.  Monoclonal antibody Ki-67: its use in histopathology.

Authors:  D C Brown; K C Gatter
Journal:  Histopathology       Date:  1990-12       Impact factor: 5.087

3.  Gastric carcinoma. A pathobiological classification.

Authors:  S C Ming
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

4.  Is DNA ploidy and proliferative activity of prognostic value in advanced gastric carcinoma?

Authors:  M I Filipe; J Rosa; A Sandey; P R Imrie; M G Ormerod; R W Morris
Journal:  Hum Pathol       Date:  1991-04       Impact factor: 3.466

5.  Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki-67.

Authors:  R Schwarting; J Gerdes; J Niehus; L Jaeschke; H Stein
Journal:  J Immunol Methods       Date:  1986-06-10       Impact factor: 2.303

6.  Prognostic value of proliferating cell nuclear antigen in gastric carcinoma.

Authors:  S Jain; M I Filipe; P A Hall; N Waseem; D P Lane; D A Levison
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

7.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

8.  Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta.

Authors:  R Bravo; R Frank; P A Blundell; H Macdonald-Bravo
Journal:  Nature       Date:  1987 Apr 2-8       Impact factor: 49.962

9.  Relationship between labeling indices of Ki-67 and BrdUrd in human malignant tumors.

Authors:  K Sasaki; K Matsumura; T Tsuji; F Shinozaki; M Takahashi
Journal:  Cancer       Date:  1988-09-01       Impact factor: 6.860

10.  Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites.

Authors:  R Bravo; H Macdonald-Bravo
Journal:  J Cell Biol       Date:  1987-10       Impact factor: 10.539

View more
  7 in total

1.  Microvessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinoma.

Authors:  G O Elpek; T Gelen; N H Aksoy; T Karpuzoglu; N Keles
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

2.  Expression of CD34 in gastric cancer and its correlation with histology, stage, proliferation activity, p53 expression and apoptotic index.

Authors:  M Tenderenda; P Rutkowski; D Jesionek-Kupnicka; R Kubiak
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

3.  Expression of proliferating cell nuclear antigen (PCNA) in gastric carcinoma: no evidence for prognostic value.

Authors:  D C Mangham; D C Rowlands; K M Newbold; G M Reynolds; J W Fielding; M T Hallissey
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

4.  Cell proliferation in prostatic carcinoma: comparative analysis of Ki-67, MIB-1 and PCNA.

Authors:  P J Hepburn; E Glynne-Jones; L Goddard; J M Gee; M E Harper
Journal:  Histochem J       Date:  1995-03

5.  Daphnoretin induces cell cycle arrest and apoptosis in human osteosarcoma (HOS) cells.

Authors:  Shoubin Gu; Jinhai He
Journal:  Molecules       Date:  2012-01-09       Impact factor: 4.411

6.  Retinoblastoma gene structure and product expression in human gastric carcinomas.

Authors:  M Constância; R Seruca; F Carneiro; F Silva; S Castedo
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

7.  Proliferating cell nuclear antigen (PCNA) immunostaining--a prognostic factor in ovarian cancer?

Authors:  H Thomas; M M Nasim; C E Sarraf; M R Alison; S Love; H E Lambert; P Price
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.